BioTissue
Miami
About BioTissue
BioTissue is an innovative technology company that uses products derived from human amniotic and umbilical cord tissues. Its medical technology platform markets innovative amniotic and umbilical cord-based products, thereby enabling physicians to avail of enhanced regenerative healing technology in eye care, wound care, and orthopedics. Tissuetech was founded in 2001 and is headquartered in Miami, Florida.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $110.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Jun 2019)
- Website: biotissue.com
- Phone: +1 786-817-6690
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/biotissue-19861 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.